Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Oxytocin may help hair grow by increasing hair growth-related genes and factors.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

A stable sheep ovarian cell line was created for studying reproduction and hormones.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

High levels of androgens during early development may cause PCOS-like symptoms.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Platelet-rich plasma may improve embryo genetics in IVF.

AMH is a reliable marker for diagnosing PCOS.

Applying estradiol to skin causes local changes but not cancer.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Ancient hair can preserve hormones, revealing health and fertility insights.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.